Iron metabolism in obesity: How interaction between homoeostatic mechanisms can interfere with their original purpose. Part II: Epidemiological and historic aspects of the iron/obesity interaction

Journal of Trace Elements in Medicine and Biology

Volumn 30, Issue , 2015, Pages 202-206

  Becker, Christiane ^a   Orozco, Mónica ^b,c   Solomons, Noel W ^b   Schümann, Klaus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Center for Studies of Sensory Impairment Aging and Metabolism Guatemala   (Guatemala)

^c Universidad de Valle   (Guatemala)

Author keywords

Epidemiology; History; Inflammation; Iron metabolism; Obesity

Indexed keywords

BENZOIC ACID DERIVATIVE; CATION TRANSPORT PROTEIN; DEFERASIROX; IRON; IRON CHELATING AGENT; METAL TRANSPORTING PROTEIN 1; PHARMACOLOGY; TRIAZOLE DERIVATIVE;

ADOLESCENT; ATTITUDE TO ILLNESS; CALORIC INTAKE; CASE REPORT; DIET; DIET SUPPLEMENTATION; DISEASE BURDEN; EPIDEMIOLOGICAL DATA; EVOLUTION; FEMALE; FOOD SECURITY; GENERAL ASPECTS OF DISEASE; GENETICS; HOMEOSTASIS; HUMAN; HYPOTHESIS; IRON DEFICIENCY; IRON INTAKE; IRON METABOLISM; LIFESTYLE; MEAT; METABOLISM; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANDEMIC; PREDATION RELEASE HYPOTHESIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; STARVATION; THRIFTY GENE HYPOTHESIS; VEGETARIAN;

ADOLESCENT; BENZOATES; CATION TRANSPORT PROTEINS; FEMALE; GENETICS; HUMANS; IRON; IRON CHELATING AGENTS; METABOLISM; MUTATION; PHARMACOLOGY; TRIAZOLES;

EID: 84940167139     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.10.012     Document Type: Review

References (50)

1. Haslam D., Rigby N. A long look at obesity. Lancet 2010, 376:85-86.
2. Spitzer M. A further look at obesity. Lancet 2010, 376:114.
3. Nie W., Zhang Y., Jee S.H., Jung K.J., Xiu Q. Obesity survival paradox in pneumonia: a meta-analysis. BMC Med 2014, 12:61.
4. Lavie C.J., Alpert M.A., Mehra M.R., Milani R.V. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 2013, 1:93-102.
5. De Schutter A., Lavie C.J., Milani R.V. The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease: the obesity paradox. Prog Cardiovasc Dis 2014, 56:401-408.
6. Carnethon M.R., De Chavez P.J., Biggs M.L., Lewis C.E., Pankow J.S., Bertoni A.G., et al. Association of weight status with mortality in adults with incident diabetes. JAMA 2012, 308:581-590.
7. Brown P.J., Konner M. An anthropological perspective on obesity. Ann N Y Acad Sci 1987, 499:29-46.
8. Stunkhard A.J. Socioeconomic status and obesity. Ciba Found Symp 1996, 201:174-182.
9. Cordain L., Watkins B.A., Mann N.J. Fatty acid composition and energy density of foods available to African hominids. Evolutionary implications for human brain development. World Rev Nutr Diet 2001, 90:144-161.
10. Carmody R.N., Wrangham R.W. The energetic significance of cooking. J Hum Evol 2009, 57:379-391.
11. Speakman J.R. A nonadaptive scenario explaining the genetic predisposition to obesity: the predation release hypothesis. Cell Metab 2007, 6:5-12.
12. Neel J.V. Diabetes mellitus: a thrifty genotype rendered detrimental by progress. Am J Hum Gen 1962, 14:353-362.
13. Pijl H. Obesity: evolution of a symptom of affluence. How food has shaped our existence. Neth J Med 2011, 69:159-166.
14. Diamond J. The double puzzle of diabetes. Nature 2003, 423:599-602.
15. Dowse G., Zimmet P., Finch C., Collins V. Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the thrifty genotypes. Am J Epidemiol 1991, 133:1093-1104.
16. Rubinstein H., Zimmet P. Phosphate, wealth, and health in Nauru. A study of lifestyle change 1993, Brolga Press, Gundaroo.
17. Knowler W., Pettitt D., Saad N., Bennett P. Diabetes mellitus in the Pima Indians: incidence risk factors and pathogenesis. Diabetes Metab Rev 1990, 6:1-27.
18. Egolf B., Lasker J., Wolf S., Potvin L. The Roseto effect: a 50-year comparison of mortality rates. Am J Pub Health 1992, 82:1089-1092.
19. O'Dea K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes 1984, 33:596-603.
20. Bassett D.R., Tremblay M.S., Esliger D.W., Copeland J.L., Barnes J.D., Huntington G.E. Physical activity and body mass index of children in an older Amish community. Med Sci Sports Exerc 2007, 39:410-415.
21. Hsueh W.C., Mitchell B.D., Aburomia R., Pollin T., Sakui H., Ehm M.G., et al. Diabetes in the old older Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care 2003, 23:595-601.
22. Szostak J., Laurant P. The forgotten face of regular physical exercise: a 'natural' anti-atherogenic activity. Clin Sci 2011, 121:91-106.
23. Booth F.W., Gordon S.E., Carlson C.J., Hamilton M.T. Waging war on modern chronic diseases: primary prevention through exercise biology. J Apll Physiol 2000, 88:774-787.
24. Momsen E.R., Hallberg L., Layrisse M., Hegsted M., Cook J.D., Merz W., et al. Estimation of available dietary iron. Am J Clin Nutr 1978, 31:134-141.
25. Hallberg L. Wheat fiber, phytates, and iron absorption. Scand J Gastroenterol 1987, 22(Suppl. 129):73-79.
26. Dallman P.R. Biochemical basis for the manifestation of iron deficiency. Ann Rev Nutr 1986, 6:13-40.
27. FAO/WHO Request of vitamin A, iron, folate and vitamin B12. FAO food and nutrition series No. 23 2004, 33-50. FAO, Rome, [revision 2004: pp 246-78].
28. Diamond J. The worst mistake in the history of the human race. Discov Mag May, 1987, 64-66.
29. Beck R. Unterfinning, ländliche Welt vor Anbruch der Moderne 1993, CH Beck-Verlag.
30. Lange (1554) quoted according to Major RH Classing descriptions of diseases 1945, 87-89. Charles C Thomas, Springfield, IL, USA. 3rd ed.
31. Sydenham T. Whole works 1718, 321. Browne, London.
32. Hoppe J.O., Marcelli H.M.A., Tainter M.L.A. A review on the toxicity of iron compounds. Am J Sci 1955, 230:558-571.
33. Green P., Evitor J.M., Sivota P., Avidor I. Secondary haemochromatosis due to prolonged iron ingestion. Isr J Med Sci 1989, (4):199-201.
34. Sazawal S., Black R.E., Ramsan M., Chwaya H.M., Stoltzfus R.J., Dutta A., et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomized, placebo-controlled trial. Lancet 2006, 367:133-143.
35. Osler M., Milman N., Heitman B.L. Consequences of removing iron fortification of flower on iron status among Danish adults: some longitudinal observations between 1987 and 1994. Prev Med 1999, 29:32-36.
36. Schmidhuber J., Shetty P. Nutrition transition, obesity & noncommunicable diseases: drivers, outlook and concerns. SCN News 2003, 29:13-19.
37. World agriculture: towards 2015/2030 2003, A FAO Perspective, FAO/Earthscan, Roma/London. J. Bruinsma (Ed.).
38. Farag Y.M.K., Gaballa M.R. Diabesity: an overview of a rising epidemic. Nephrol Dial Transpl 2011, 26:28-35.
39. WHO Obesity and Overweight Fact Sheets No. 311 2006, http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
40. Levitt N., Katzenellenbogen J.M., Bradshaw D., Hofmann M.N., Bonnici F. The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care 1993, 16:601-607.
41. Stoltzfus R.J., Dreyfuss M.L. Guideline for the use of iron supplementation to prevent and treat iron deficiency anemia 1998, ILSI Press, Washington.
42. McLean E., Egli I., Cogswell M., de Benoist B., Wojdyla D. Worldwide prevalence of anemia in children, pregnant women and non-pregnant women of reproductive age. Nutritional anemia 2007, 1-12. Sight and Life Press, Ch I. K. Kraemer, M.D. Zimmermann (Eds.).
43. McLean E., Cogswell M., Egli I., Wojdyla D., de Benoist B. Worldwide prevalence of anemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Publ Health Nutr 2009, 12:444-454.
44. Allen L.H., Rosado J.L., Casterline J.E., Lopez P., Munoz E., Garcia O.P., et al. Lack of hemoglobin response to iron supplementation in anemic Mexican preschoolers with multiple micronutrient deficiencies. Am J Clin Nutr 2000, 71:1485-1494.
45. Asobayire S., Adou P., Davidsson L., Cook J.D., Hurrell R.F. Prevalence of iron-deficiency with and without concurrent anemia in populations groups with high prevalences of malaria and other infections: a study in Cote d'Ivoire. Am J Clin Nutr 2001, 74:776-782.
46. Schümann K., Romero-Abal M.E., Mäurer A., Luck T., Beard J., Murray-Kolb L., et al. Haematological response to HAEM iron or ferrous sulphate mixed with refried black beans in moderately anaemic Guatemalan pre-school children. Public Health Nutr 2005, 8:572-581.
47. Flint J., Harday R.M., Boyce A.J., Clegg J.B. The population genetics of the haemoglobinopathies. Bailliers Clin Haematol 1993, 6:215-262.
48. Schümann K., Solomons N.W. Can iron supplementation be reconciled with benefits and risks in areas hyperendemic for malaria. Food Nutr Bull 2013, 34:349-356.
49. Morus T. Utopia 1516, Löwen.
50. Menzie C.M., Yanoff L.B., Denkinger B.I., McHugh T., Sebring N.G., Calis K.A., et al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 2008, 108:145-148.